ArticleJournal of the National Cancer Institute2016
What to Do With the Participants/Patients in Phase III Clinical Cancer Trials That Have Been Stopped by the FDA.
Frank L MeyskensPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it